All News #Library
Biotech
Bioxytran Completes $1.2 Million Private Placement
20 Mar 2026 //
GLOBENEWSWIRE
Bioxytran Reports Positive Phase 1B/2A Results For Prolectin-M
02 Mar 2026 //
PHARMIWEB
Bioxytran Shows Positive Ph2 Data for ProLectin-M Viral Clearance
11 Feb 2026 //
GLOBENEWSWIRE
Bioxytran CEO To Present At Noble Capital Markets Conference
04 Feb 2026 //
ACCESSWIRE
Bioxytran Highlights Momentum In Multi-Platform Pipeline Update
30 Jan 2026 //
PHARMIWEB
Bioxytran Advances Pipeline in Corporate Update
29 Jan 2026 //
ACCESSWIRE
Bioxytran Announces Stock Coverage by Independent Research Firm
13 Nov 2025 //
GLOBENEWSWIRE
Bioxytran Wraps Up Trial For Broad-Spectrum Antiviral Drug
29 Oct 2025 //
GLOBENEWSWIRE
Bioxytran Reveals Precision Diagnostics for Tissue Oxygenation
15 Aug 2025 //
GLOBENEWSWIRE
Bioxytran`s Antiviral Technology Revolutionizes Respiratory
07 Aug 2025 //
GLOBENEWSWIRE
Bioxytran Secures a Source of GMP Quality Camel Hemoglobin
18 Jun 2025 //
GLOBENEWSWIRE
Bioxytran Completes Dose Optimization of Antiviral, ProLectin-M
12 May 2025 //
GLOBENEWSWIRE
Bioxytran Celebrates 50 Years of Mitochondrial Research
11 Apr 2025 //
GLOBENEWSWIRE
Bioxytran Develops Treatment for Flu in Chickens, Saving Billion
12 Mar 2025 //
GLOBENEWSWIRE
Bioxytran Secures $1.6 Million For Note Extinction, Development
22 Jan 2025 //
GLOBENEWSWIRE
Bioxytran Reports BARDA Interest After Techwatch Light Meeting
07 Jan 2025 //
GLOBENEWSWIRE
Bioxytran™s Oral Drug to Enter Dose Optimization Clinical Trial for COVID-19
21 Feb 2024 //
GLOBENEWSWIRE
Bioxytran Initiates a Trial of Oral ProLectin-M for COVID-19 Patients
08 Aug 2023 //
GLOBENEWSWIRE
Bioxytran Peer-Reviewed Journal in œVaccines Contains Mechanism Capable
27 Jun 2023 //
GLOBENEWSWIRE
Bioxytran Tests Acellular Oxygen Carrier BXT-25 in Pre-Clinical Trials
19 Apr 2023 //
GLOBENEWSWIRE
Bioxytran Announces Positive Phase 2 Trial Results were Featured in Journal
29 Mar 2023 //
GLOBENEWSWIRE
Nature Reviews Drug Discovery Article Offers Support for ProLectin-I
22 Feb 2023 //
GLOBENEWSWIRE
Bioxytran Receives Approval to Initiate Trials with ProLectin-I
06 Feb 2023 //
GLOBENEWSWIRE

Market Place
Sourcing Support